Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5Y86

Crystal structure of kinase

Summary for 5Y86
Entry DOI10.2210/pdb5y86/pdb
DescriptorDual specificity tyrosine-phosphorylation-regulated kinase 3, 7-METHOXY-1-METHYL-9H-BETA-CARBOLINE, PHOSPHATE ION, ... (6 entities in total)
Functional Keywordskinase, inhibitor, signaling protein
Biological sourceHomo sapiens (Human)
Cellular locationNucleus : O43781
Total number of polymer chains1
Total formula weight67124.51
Authors
Kim, K.L.,Cha, J.S.,Cho, Y.S.,Kim, H.Y.,Chang, N.P.,Cho, H.S. (deposition date: 2017-08-18, release date: 2018-05-02, Last modification date: 2024-11-13)
Primary citationKim, K.,Cha, J.S.,Cho, Y.S.,Kim, H.,Chang, N.,Kim, H.J.,Cho, H.S.
Crystal Structure of Human Dual-Specificity Tyrosine-Regulated Kinase 3 Reveals New Structural Features and Insights into its Auto-phosphorylation
J. Mol. Biol., 430:1521-1530, 2018
Cited by
PubMed Abstract: Dual-specificity tyrosine-regulated kinases (DYRKs) auto-phosphorylate a critical tyrosine residue in their activation loop and phosphorylate their substrate on serine and threonine residues. The auto-phosphorylation occurs intramolecularly and is a one-off event. DYRK3 is selectively expressed at a high level in hematopoietic cells and attenuates erythroblast development, leading to anemia. In the present study, we determined the crystal structure of the mature form of human DYRK3 in complex with harmine, an ATP competitive inhibitor. The crystal structure revealed a phosphorylation site, residue S350, whose phosphorylation increases the stability of DYRK3 and enhances its kinase activity. In addition, our structural and biochemical assays suggest that the N-terminal auto-phosphorylation accessory domain stabilizes the DYRK3 protein, followed by auto-phosphorylation of the tyrosine of the activation loop, which is important for kinase activity. Finally, our docking analysis provides information for the design of novel and potent therapeutics to treat anemia.
PubMed: 29634919
DOI: 10.1016/j.jmb.2018.04.001
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon